Endurant Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,303
Closed -$552K 22
2023
Q4
$552K Sell
7,303
-19,848
-73% -$1.26M 3.16% 12
2023
Q3
$1.79M Sell
27,151
-30,885
-53% -$2.31M 1.61% 23
2023
Q2
$4.72M Sell
58,036
-1,867
-3% -$133K 4.12% 7
2023
Q1
$3.56M Buy
59,903
+19,451
+48% +$1.08M 1.83% 16
2022
Q4
$1.97M Sell
40,452
-30,083
-43% -$1.39M 0.8% 25
2022
Q3
$3.64M Buy
70,535
+23,093
+49% +$1.37M 1.18% 24
2022
Q2
$2.49M Sell
47,442
-83,934
-64% -$5.84M 0.87% 30
2022
Q1
$11.3M Sell
131,376
-15,553
-11% -$1.28M 2.97% 9
2021
Q4
$12M Sell
146,929
-32,359
-18% -$2.36M 2.9% 11
2021
Q3
$11.9M Sell
179,288
-38,603
-18% -$2.74M 2.71% 11
2021
Q2
$14.6M Buy
+217,891
New +$13.5M 4.01% 6
2019
Q2
Sell
-121,823
Closed -$3.51M 75
2019
Q1
$3.51M Buy
+121,823
New +$3.01M 1.39% 22

Other funds holding THC

Endurant Capital Management's THC Position: Q1 2024 in Review

Endurant Capital Management sold out of Tenet Healthcare (THC) in Q1 2024, closing a stake of 7,303 shares — an estimated $552K sold.

Endurant Capital Management first reported a position in THC in Q1 2019 and held it in 12 quarters. The position peaked at $14.6M in Q2 2021. 460 funds tracked by Wall St. Rank hold THC as of Q1 2024.

  • Endurant Capital Management reported no remaining Tenet Healthcare position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 7,303 Tenet Healthcare shares in Q1 2024, an estimated $552K.
  • Endurant Capital Management first reported a position in Tenet Healthcare in Q1 2019 and held it in 12 quarters.
  • Endurant Capital Management's Tenet Healthcare position peaked at $14.6M in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.